COVID-19 pandemic: Impact on the management of patients with hepatocellular carcinoma at a tertiary care hospital

• Katharina Pomej,

  Roles Conceptualization, Data curation, Formal analysis, Writing – original draft, Writing – review & editing

  Affiliations Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria, Liver Cancer (HCC) Study Group Vienna, Medical University of Vienna, Vienna, Austria

  https://orcid.org/0000-0002-2807-3565

  ⨯
• Bernhard Scheiner,

  Roles Conceptualization, Formal analysis, Writing – review & editing

  Affiliations Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria, Liver Cancer (HCC) Study Group Vienna, Medical University of Vienna, Vienna, Austria, Vienna Hepatic Hemodynamic Laboratory, Medical University of Vienna, Vienna, Austria, Rare Liver Disease (RALID) Centre of the ERN RARE-LIVER, Medical University of Vienna, Vienna, Austria

  ⨯
• Lukas Hartl,

  Roles Data curation, Writing – review & editing

  Affiliations Liver Cancer (HCC) Study Group Vienna, Medical University of Vienna, Vienna, Austria, Vienna Hepatic Hemodynamic Laboratory, Medical University of Vienna, Vienna, Austria

  ⨯
• Lorenz Balcar,

  Roles Data curation, Writing – review & editing

  Affiliations Liver Cancer (HCC) Study Group Vienna, Medical University of Vienna, Vienna, Austria, Vienna Hepatic Hemodynamic Laboratory, Medical University of Vienna, Vienna, Austria

  ⨯
• Tobias Meischl,

  Roles Writing – review & editing

  Affiliations Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria, Liver Cancer (HCC) Study Group Vienna, Medical University of Vienna, Vienna, Austria

  https://orcid.org/0000-0002-1716-9166

  ⨯
• Mattias Mandorfer,

  Roles Writing – review & editing

  Affiliations Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria, Vienna Hepatic Hemodynamic Laboratory, Medical University of Vienna, Vienna, Austria, Rare Liver Disease (RALID) Centre of the ERN RARE-LIVER, Medical University of Vienna, Vienna, Austria

  ⨯
• Thomas Reiberger,

  Roles Writing – review & editing

  Affiliations Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria, Vienna Hepatic Hemodynamic Laboratory, Medical University of Vienna, Vienna, Austria, Rare Liver Disease (RALID) Centre of the ERN RARE-LIVER, Medical University of Vienna, Vienna, Austria, Christian Doppler Laboratory for Portal Hypertension and Liver Fibrosis, Medical University of Vienna, Vienna, Austria

  ⨯
• Christian Müller,

  Roles Writing – review & editing

  Affiliations Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria, Liver Cancer (HCC) Study Group Vienna, Medical University of Vienna, Vienna, Austria

  ⨯
• Michael Trauner,

  Roles Writing – review & editing

  Affiliations Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria, Rare Liver Disease (RALID) Centre of the ERN RARE-LIVER, Medical University of Vienna, Vienna, Austria

  ⨯
• Matthias Pinter

  Roles Conceptualization, Data curation, Formal analysis, Supervision, Writing – original draft, Writing – review & editing

  * E-mail: matthias.pinter@meduniwien.ac.at

  Affiliations Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria, Liver Cancer (HCC) Study Group Vienna, Medical University of Vienna, Vienna, Austria, Rare Liver Disease (RALID) Centre of the ERN RARE-LIVER, Medical University of Vienna, Vienna, Austria

  ⨯